Results 161 to 170 of about 113,160 (301)
ABSTRACT Introduction Esophageal perforation (EP) is a rare but life‐threatening condition, and most cases are due to iatrogenic causes. The rest occur spontaneously, due to malignancies, or trauma. The mortality rates can approach 50%, and delayed diagnosis of EP exacerbates patient outcomes.
Mason Marshall +3 more
wiley +1 more source
Cutaneous Paraconiothyrium cyclothyrioides Infection in Lung Transplant Recipient, Georgia, USA. [PDF]
Mackey C +8 more
europepmc +1 more source
Cubebene‐related sesquiterpenes, found across diverse biological sources, exhibit promising pharmacological activities, including anti‐inflammatory, neuroprotective, and anticancer effects. This review highlights their molecular diversity, ADME profiles, and predicted multitarget interactions, underscoring their therapeutic relevance and potential in ...
Khadija Boualam +4 more
wiley +1 more source
Pathological lung tissue changes in common infectious diseases. [PDF]
Nampalliwar A +5 more
europepmc +1 more source
Demographic and Comorbidity Associations With Disease Severity and Bony Dehiscence in AFRS
ABSTRACT Objective(s) The purpose of this study is to explore and describe possible demographic factors and comorbidities as they relate to disease severity of allergic fungal rhinosinusitis (AFRS) on initial presentation. Methods A retrospective review was conducted on 153 patients with AFRS seen at a tertiary care center. Demographics, comorbidities,
Diana Bigler +6 more
wiley +1 more source
Non-<i>fumigatus Aspergillus</i>-associated pulmonary events: a diagnostic challenge. [PDF]
Godet C +15 more
europepmc +1 more source
Phage therapy shows promising efficacy against MDR, XDR, and PDR Pseudomonas aeruginosa infections across different models and administration routes. Evidence highlights reduced mortality, bacterial clearance, and synergy with antibiotics, while emphasizing the need for standardized protocols and advanced delivery systems to support clinical ...
Gustavo Aparecido da Cunha +7 more
wiley +1 more source
Contribution of fungal diseases to the U.S. chronic disease burden. [PDF]
Ghai RR +10 more
europepmc +1 more source
ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang +3 more
wiley +1 more source

